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Introduction
Muscle weakness is associated with exercise intolerance 
and a poorer prognosis for people with chronic obstructive 
pulmonary disease (ATS and ERS 1999). Therefore, 
the inclusion of progressive resistance exercise during 
pulmonary rehabilitation has been recommended (Troosters 
et al 2005, ATS and ERS 2006, Ries et al 2007). A recent 
systematic review of progressive resistance exercise 
for people with chronic obstructive pulmonary disease 
demonstrated moderate to large effects for increases in 
upper and lower body strength after progressive resistance 
exercise (O’Shea et al 2004). However, there was limited 
information regarding the effect on broader outcomes 
such as task performance (activity) and social roles 
(participation). The specific effects of progressive resistance 
exercise for people with chronic obstructive pulmonary 
disease also remain unclear as trials have often compared 
resistance exercise with endurance training or included it 
as part of a mixed program (O’Shea et al 2004). Little is 
known about the effectiveness of home-based progressive 
resistance exercise programs as trials have predominantly 
been undertaken in supervised outpatient settings using 
machine weights (O’Shea et al 2004). Moreover, it is unclear 
how well changes after progressive resistance exercise are 
maintained, with conflicting findings from the only two 
located trials (Troosters et al 2000, Ortega et al 2002).
The aim of this investigation was to further understand the 
role and contribution of progressive resistance exercise in 
pulmonary rehabilitation. The research questions were:
1.  Does a 12-week, predominantly home-based program of 
progressive resistance exercises reduce impairements, 
activity limitations and participation restrictions in 
people with chronic obstructive pulmonary disease?
2.  Are any gains maintained 12 weeks after the cessation 
of the program?
Method
Design
A parallel-group single-blind randomised trial was 
conducted across four sites, including three regional health 
services and one large metropolitan hospital. People with 
chronic obstructive pulmonary disease were recruited 
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via pulmonary rehabilitation databases, medical clinics, 
and media promotions. Group allocation sequence was 
generated by a member of the research team not involved 
in participant recruitment, and concealed in envelopes until 
after completion of baseline measurement. Participants were 
stratified according to past pulmonary rehabilitation status 
(rehabilitation or no rehabilitation) and randomly allocated 
from each stratum, via block randomisation, to one of two 
groups: progressive resistance exercise or control (Altman 
and Bland 1999). Participants were advised of group 
allocation (after initial assessment) by a member of the 
research team responsible for recruitment. Participants were 
assessed prior to the intervention (0 weeks), immediately 
after intervention (12 weeks), and 12 weeks after intervention 
had ceased (24 weeks). All measurement sessions were 
conducted by an independent and trained assessor, blinded 
to group allocation. Ethics approval was obtained from all 
four study sites.
Participants
Inclusion criteria were: a diagnosis of chronic obstructive 
pulmonary disease (McKenzie et al 2003), written informed 
consent, and no pulmonary rehabilitation in the previous 12 
months. Participants were excluded if they had respiratory 
conditions other than chronic obstructive pulmonary disease, 
or unstable medical conditions limiting the performance of 
progressive resistance exercise. Lung function was measured 
using spirometry, performed according to American Thoracic 
Society guidelines (ATS 1995), to monitor disease stability. 
The key measures were forced vital capacity (FVC), forced 
expiratory volume in one second (FEV1), FEV1/FVC, and 
the percentage predicted of FEV1 (FEV1 % predicted).
Intervention
The experimental group undertook a progressive resistance 
exercise program consisting of six exercises three times per 
week for 12 weeks. One session per week was conducted in 
an outpatient clinic under the supervision of an experienced 
physiotherapist; the remaining two sessions were performed 
independently at home. Exercises included hip abduction in 
standing, simulated lifting, sit-to-stand, seated row, lunges, 
and chest press. For each exercise, participants attempted to 
complete three sets of 8 to 12 repetitions maximum against 
elasticised resistance bands (Kraemer et al 2002). Resistance 
level (ie, band colour) was increased when participants could 
perform three sets of 12 repetitions maximum with correct 
technique through the full range of movement. An exercise 
logbook was provided to record intensity, frequency, and 
duration of exercise sessions. After 12 weeks, the resistance 
bands were left with participants but ongoing exercise was 
a personal choice.
The control group received no intervention. They were 
instructed not to commence any form of progressive 
resistance exercise or to alter their baseline exercise routine 
significantly. Exercise levels of all participants were 
reviewed via telephone at 6, 12, 18, and 24 weeks of the 
trial.
Outcome measures
Outcomes were categorised under the headings impairments, 
activity limitations, and participation restrictions according 
to the International Classification of Functioning, Disability 
and Health (WHO 2002). The primary outcomes were 
strength (knee extensor, hip abductor, shoulder horizontal 
flexor, and shoulder flexor) and walking capacity.
Impairments: Strength was measured using hand-held 
dynamometry and reported in kg. Three trials each of knee 
extensor, hip abductor, shoulder horizontal flexor, and 
shoulder flexor strength were performed for both right and 
left limb, with the final two trials averaged across right and 
left limbs. Good test-retest reliability (ICC > 0.79) over a 
two-week interval has been demonstrated for muscle strength 
measures obtained via this method for people with chronic 
obstructive pulmonary disease (O’Shea et al 2007b).
Physical and psychological impairments were measured 
with the Chronic Respiratory Disease Questionnaire, for 
which good reliability and validity has been reported in 
chronic obstructive pulmonary disease populations (Guyatt 
et al 1987). The questionnaire was administered by an 
interviewer and each domain (dyspnoea, fatigue, emotion 
and mastery) was scored from 1 to 7 where 1 represents 
maximum impairment and 7 represents no impairment.
Activity limitations: Walking capacity was measured using 
the 6-minute Walk Test (Butland et al 1982), and reported 
as distance walked in metres. The test was administered 
according to American Thoracic Society guidelines (Crapo 
et al 2002).
Mobility was measured using the Timed Up and Go test and 
reported in seconds with a lower score representing good 
performance. Three trials were performed, with the times 
for the final two trials averaged. The test is highly repeatable 
(Podsiadlo and Richardson 1991).
Upper limb activity was measured using the Grocery Shelving 
Test and reported in seconds with a lower score representing 
good performance. The test required participants to place 
10 items (410g each) from each of two grocery bags onto a 
shelf 15 cm above shoulder height as fast as possible. Three 
trials were performed, with times for the final two trials 
averaged. High test-retest reliability over a six week interval 
has been demonstrated for people with chronic obstructive 
pulmonary disease (Hill et al 2001).
Participants rated their own activity performance using the 
Patient-Specific Functional Scale (Stratford et al 1995). 
Participants nominated up to five tasks they had difficulty 
with because of their breathing problem and rated their 
performance on each of them (from 0 to 10). The score was 
determined by averaging the individual ratings (Stratford et 
al 1995). Moderate test-retest reliability has previously been 
demonstrated in people with chronic obstructive pulmonary 
disease (O’Shea et al 2005).
Participation restrictions: Participation restrictions were 
measured using the London Handicap Scale (Harwood and 
Ebrahim 1995) which has moderate test-retest reliability for 
people with chronic obstructive pulmonary disease (ICC = 
0.71) (O’Shea et al 2005). The scale considers disadvantage 
in six dimensions: mobility, physical independence, 
occupation, social integration, orientation, and economic 
self-sufficiency. Participants answered questions about these 
dimensions and a handicap score (0 to 100) was determined, 
where a score of 100 implies no disadvantage and a score 
of 0 represents maximum disadvantage (Harwood and 
Ebrahim 1995).
Data analysis
In estimating sample size, a minimum clinical improvement 
in muscle strength of 15% was regarded as worth detecting. 
The standard deviation of a similar population was 18% 
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(O’Shea et al 2004). Therefore, to have 80% power of 
detecting a 15% difference, 45 participants were required. 
The minimum clinical improvement in walking capacity 
worth detecting was regarded as 80 m (Wise and Brown 
2004). The standard deviation of a similar population 
was 95.1 m (Sciurba et al 2003). Therefore, to have 80% 
power of detecting an 80 m difference, 44 participants were 
required. Taken together, and allowing for an attrition rate 
of 20%, 56 participants were required.
Two-way ANOVA for repeated measures was used to 
examine changes occurring between baseline (Week 0) and 
immediately after intervention (Week 12), and baseline 
(Week 0) and 12 weeks after cessation of intervention 
(Week 24). Intention-to-treat analysis via the carry forward 
method was used when withdrawing participants could not 
be reassessed at follow up (Hollis and Campbell 1999).
Results
Flow of participants through the trial
Fifty-seven volunteers (22 male, 35 female) were recruited 
between April and September 2004. Fifty-four participants 
were randomly allocated to either the experimental (Exp 
= 27) or control (Con = 27) group, after two female 
participants withdrew (surgery, personal choice), and 
one male volunteer was excluded at baseline assessment 
due to an incorrect diagnosis (chronic heart failure). The 
characteristics of each group were similar at baseline (Table 
1). Of the 27 participants in each group, 16 people (59%) 
had completed pulmonary rehabilitation, six (22%) were 
on long-term oxygen therapy, approximately 70% reported 
exercising nil to less than twice weekly. Cardiovascular (Exp 
= 21, Con = 25) and musculoskeletal (Exp = 27, Con = 24) 
co-morbidities were similar across groups. There was very 
little deterioration in the participants’ condition over the 24 
weeks of the trial. At baseline, their % predicted  FEV1 was 
51% (SD 23), at 12 weeks it was 50% (SD 22), and at 24 
weeks it was unchanged at 50% (SD 24). At baseline, their 
FEV1/FVC was 50% (SD 16), at 12 weeks it was 48% (SD 
14), and at 24 weeks it was 47% (SD 15).
Ten participants (Exp = 7, Con = 3) withdrew during the 
first 12 weeks of the study, and a further three people (Exp 
= 1, Con = 2) withdrew prior to the Week 24 measurement 
(Figure 1). Reasons for withdrawal included respiratory 
exacerbation (Exp = 3, Con = 1), illness unrelated to chronic 
obstructive pulmonary disease (Exp = 1, Con = 1), injury 
unrelated to the trial (Exp = 2), family issues (Exp = 1, Con 
= 1), personal choice (Con = 2), or change in treatment (Exp 
= 1). Participants who withdrew from the trial were heavier 
(t(52) = –2.24, p = 0.03), had a higher body mass index (t(52) 
= –2.71, p = 0.01), had reduced baseline 6-minute walk 
distance (t(52) = 2.17, p = 0.03) and were more likely to have 
never completed pulmonary rehabilitation when compared 
to participants who completed the trial (χ2 = 4.31, p = 0.04) 
(Table 1). 
Compliance with trial method
Twenty out of 27 participants (74%) in the experimental 
group completed a mean 30.5 (SD 5.7) out of 36 exercise 
sessions (85%, range 44–100%). Five of these 20 participants 
had to cease exercising prior to the end of the 12 week 
intervention because of respiratory exacerbation (n = 2), 
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Table 1. Mean (SD) of characteristics of participants by group and by completion of the trial.
Characteristic Participants by group Participants by completion
Exp
(n = 27)
Con
(n = 27)
Completed
(n = 41)
Withdrew
(n = 13)
Age (yr) 66.9
(7.0)
68.4
(9.9)
67.1
(8.7)
69.7
(8.1)
Height (m) 1.63
(0.08)
1.64
(0.09)
1.64
(0.09)
1.62
(0.10)
Weight (kg) 67.9
(15.3)
74.7
(19.6)
68.4
(16.1)
80.5
(20.2)
Body Mass Index (kg/m2) 25.5
(5.1)
27.8
(7.9)
25.3
(5.6)
30.8
(8.4)
Number co-morbidities 2.3
(1.4)
2.7
(1.6)
2.5
(1.2)
2.5
(1.8)
Number medications 6.5
(3.9)
5.5
(2.4)
5.4
(2.5)
8.0
(4.4)
History of smoking (packs/day x 
years smoking)
40.0
(29.4)
26.5
(21.5)
31.4
(27.5)
39.0
(22.3)
Time since quit smoking (yr) 10.1
(10.5)
9.4
(12.7)
10.3
(12.4)
8.1
(8.1)
FEV1 (% predicted) 49
(25)
52
(22)
52
(24)
46
(20)
FEV1/FVC (%) 50
(16)
49
(15)
49
(15)
52
(17)
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hospitalisation unrelated to chronic obstructive pulmonary 
disease (n = 1), injury secondary to motor vehicle accident 
(n = 1), and surgery (n = 1). Therefore, 15 participants 
completed the full 12-week program, and performed an 
average 32.7 (SD 3.9) out of 36 exercise sessions (91%, 
range 64–100%), exercised at an intensity greater than or 
equal to ‘somewhat hard’ (Borg 1982), and demonstrated 
good progression of their exercise by increasing the colour 
and number of resistance bands. The seven participants 
who withdrew from the experimental group completed a 
mean 5.3 (SD 4.3) out of 36 exercise sessions (15%, range 
0–33%). At Week 24, 15 out of the 19 participants (79%) 
in the experimental group reported continuing or resuming 
some level of resistance exercise during the follow-up 
period. However, only eight participants (42%) exercised 
for the full 12 weeks, and exercise frequency and intensity 
were also reduced.
No participants in the control group reported any changes in 
their exercise habits or level of activities across the course 
of the trial.
Effect of intervention
Group data for all outcomes are presented in Table 2 
according to intention-to-treat analysis, while individual 
data for the three measurement occasions are presented in 
Table 3 (see eAddenda for Table 3). In terms of the primary 
outcomes, the experimental group had increased their 
knee extensor strength by 4.9 kg (95% CI 1.1 to 8.7, p = 
0.01) more than the control group immediately after the 
intervention at Week 12. This is equivalent to a 17% greater 
increase in strength than the control group. However, this 
gain was not maintained at Week 24. No difference was 
found between the groups for any of the other primary or 
secondary outcomes (p > 0.05).
Week
Experimental Group
Progressive resistance exercise 
program
3 x week
Control Group
Nothing
Figure 1. Design and flow of participants through the trial.
0
NothingNothing
12
24
Participants recruited (n = 57)
Ineligible (n = 1)
Eligible (n = 56)
Elected not to participate (n = 2)
Measured impairments x 2, activity limitations x 4, participation restrictions x 1
Randomised (n = 54)
 (n = 27)     (n = 27)
Measured impairments x 2, activity limitations x 4, participation restrictions x 1
     Completed program (n = 15)
     Partially completed program (n = 5)
 Total (n = 20)    (n = 24)
Measured impairments x 2, activity limitations x 4, participation restrictions x 1
     Completed program (n = 14)
     Partially completed program (n = 5)
 Total (n = 19)    (n = 22)
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The only adverse events were mild muscle soreness in the 
initial stages of progressive resistance exercise, one episode 
of acute low back pain, and one mild adductor strain which 
resolved after a week’s rest. There were no reports of 
aggravation or exacerbation of pre-existing conditions as a 
result of the exercise program.
Feasibility of intervention
Due to the large number of participants unable to complete 
the intervention, post-hoc per protocol analyses were 
conducted to examine the efficacy of progressive resistance 
exercise for those participants who were able to complete 
the intervention (Exp = 15, Con = 24). Group data for all 
outcomes are presented in Table 4 according to a per protocol 
analysis. In terms of the primary outcomes, the experimental 
group had increased their knee extensor strength by 9.2 
kg (95% CI 4.8 to 13.5, p = < 0.001), their hip abductor 
strength by 6.3 kg (95% CI 1.2 to 11.5, p = 0.03), and 
their shoulder flexor strength by 3.9 kg (95% CI 0.7 to 7.1, 
p = 0.04) more than the control group immediately after the 
intervention at Week 12. This is equivalent to a 20% greater 
increase in strength than the control group. However, these 
gains were not maintained at Week 24. No difference was 
found between the groups for the other primary outcomes 
of shoulder horizontal flexor strength or walking capacity 
(p = 0.17 and 0.78).
In terms of secondary outcomes, the experimental group 
had decreased their dyspnoea by 1.3 points (95% CI 0.5 to 
2.0, p = 0.001) and their fatigue by 1.0 point (95% CI 0.3 to 
1.8, p = 0.02) more than the control group immediately after 
the intervention at Week 12. This exceeds the minimum 
clinically-worthwhile difference of 0.5 units (Jaeschke et al 
1989, Lacasse et al 1997). However, these gains were not 
maintained at 24 weeks (p = 0.40 and 0.44).
Discussion
Compared with no intervention, a predominantly home-
based progressive resistance exercise program resulted in 
modest increases in knee extensor strength in people with 
chronic obstructive pulmonary disease, but no reduction in 
physical and psychological impairment, activity limitations, 
or participation restrictions. These findings suggest that 
progressive resistance exercise is not effective for people 
with chronic obstructive pulmonary disease, and seemingly 
contrast with previous investigations (O’Shea et al 2004). 
However, this trial used an intention-to-treat analysis to 
examine trial outcomes which may have underestimated 
effects compared with previous studies.
A number of factors may have influenced the lack of 
effectiveness of progressive resistance exercise. A 
relatively low completion rate was seen, and is likely to 
have influenced outcomes. The ability and willingness 
of participants to complete exercise is just as important 
for clinicians to consider as efficacy, but has received 
little attention in the literature. Health issues were the 
main reason that participants withdrew or were unable to 
continue the intervention in this trial. Fluctuating health 
is a feature of chronic obstructive pulmonary disease and 
may limit the ability to perform a progressive resistance 
exercise program consistently or at the required intensity to 
achieve meaningful changes. Therefore, the implementation 
of strategies to maximise adherence and the resumption of 
exercises after periods of illness needs to be considered by 
clinicians when prescribing progressive resistance exercise 
in this population.
Particular features of the program may also have limited 
overall effectiveness. The current program was largely 
home-based, whereas most previous investigations have 
been conducted in closely-supervised centre-based settings 
(O’Shea et al 2004). The only other home-based progressive 
resistance exercise program tested also demonstrated no 
difference in outcomes compared with no intervention 
(O’Hara et al 1984). Similarly, home-based progressive 
resistance exercise programs for healthy older adults 
have generally reported smaller effects than centre-based 
programs (Dodd et al 2003), which may be a consequence 
of less supervision and lower exercise intensities (Dodd 
et al 2003). Logbook recordings in the current trial 
provided evidence of suitable exercise intensities and 
progression; therefore, minimal supervision in combination 
with fluctuating health may have influenced participant 
completion rate. Greater supervision in the early stages of 
progressive resistance exercise or after periods of ill-health 
may be imperative so that participants gain confidence and 
maintain exercises over a long period.
Whilst the overall effectiveness of the program was shown 
to be limited, post hoc per protocol analysis suggested that 
progressive resistance exercise was effective in increasing 
muscle strength if participants undertook the whole program. 
The use of elasticised resistance bands led to increases in 
strength of 27–46% which is similar to increases previously 
reported using other forms of equipment in people with 
chronic obstructive pulmonary disease (weighted mean 
differences 23–36%, O’Shea et al 2004), and healthy older 
adults (weighted mean differences 27–43%, Dodd et al 2003). 
The program also led to reduced dyspnoea and fatigue, two of 
the most commonly-reported symptoms limiting activity for 
people with chronic obstructive pulmonary disease (Killian 
et al 1992). However, reductions in these impairments did 
not lead to improvements in activity or participation.
The initial degree of activity limitation may affect the degree 
of change possible after progressive resistance exercise 
(Chandler et al 1998, Dodd et al 2003); therefore, where 
no activity limitation exists for a task prior to progressive 
resistance exercise, increases in strength may not result in 
improvements in task performance (Chandler et al 1998). 
Additionally, interventions aimed at reducing impairments 
(such as progressive resistance exercise) that are delivered 
short-term, may have limited value in reducing activity 
limitations and participation restrictions (Harwood and 
Ebrahim 1995). Moreover, due to the broad and varied 
nature of activity and participation between individuals, 
finding suitable measures to detect changes in activity 
and participation may also be challenging (O’Shea et al 
2007c).
Twelve weeks after cessation of the intervention, no 
differences were found between participants in the 
experimental versus the control group. Even those 
participants completing the full exercise program 
demonstrated dissipation of gains made in increasing muscle 
strength and decreasing dyspnoea and fatigue. These findings 
are consistent with an investigation examining long-term 
outcomes of progressive resistance exercise in people with 
chronic obstructive pulmonary disease (Ortega et al 2002), 
and general investigations of detraining (Mujika and Padilla 
2001), suggesting that ongoing exercise performance is 
required to maintain gains. Therefore, future research in this 
population should explore the optimal doses of progressive 
resistance exercise for maintenance.
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A key factor in the success of maintenance progressive 
resistance exercise programs is likely to be long-term 
adherence to exercise. Marked reductions in adherence have 
been reported in the general population within six-months 
of commencing an exercise program (Dishman 1982), and 
adherence may be further reduced when chronic health 
conditions are present (Sabate 2003). Reduced long-term 
adherence to exercise after pulmonary rehabilitation has been 
demonstrated in people with chronic obstructive pulmonary 
disease despite ongoing supervision and support (Brooks et 
al 2002). Strategies, such as education, contracts, logbooks, 
and ongoing supervision or review, have been suggested to 
maximise adherence to interventions aimed at improving 
health (Ferri et al 1998, O’Shea et al 2007a). However, 
greater understanding of the factors influencing long-term 
adherence to exercise by people with chronic obstructive 
pulmonary disease is required in order to develop effective 
strategies to maximise long-term outcomes.
This study represents one of the first attempts to examine 
the effects of progressive resistance exercise on activity and 
participation in people with chronic obstructive pulmonary 
disease. The exercise program was clinically feasible, 
requiring minimal supervision and simple and inexpensive 
equipment. The trial investigated a heterogeneous sample 
reflecting the diversity of people with chronic obstructive 
pulmonary disease referred to pulmonary rehabilitation. This 
trial is also the only investigation of progressive resistance 
exercise in this population to examine effectiveness using 
intention-to-treat analysis. A limitation of the trial was the 
number of participants unable to complete the intervention 
and/or lost to follow up, which may have increased the 
likelihood of Type II statistical error for some outcomes. 
However, participant withdrawal is the real challenge that 
clinicians face in prescribing exercise in this population.
In conclusion, a 12-week, predominantly home-based, 
progressive resistance exercise program led to modest, 
short-term improvements in knee extensor strength in people 
with chronic obstructive pulmonary disease, but this did not 
carry over to improvements in activity and participation. 
This minimally-supervised progressive resistance exercise 
program was shown to be relatively safe for people with 
chronic obstructive pulmonary disease, with only two minor 
musculoskeletal adverse events reported. However, many 
participants were unable to complete the full program, 
highlighting the need for greater understanding of factors 
that can influence adherence to exercise in this population. 
Future research should determine optimal prescription of 
exercise for long-term programs.
eAddendum: Table 3 at www.physiotherapy.asn.au
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